tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CLNN Stock Latest News

Clene announces peer-reviewed publication on CNM-Au8
The FlyClene announces peer-reviewed publication on CNM-Au8
1M ago
CLNN
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®
PremiumPress Releases
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®
1M ago
CLNN
Clene expects cash to fund operations into 4Q24
PremiumThe Fly
Clene expects cash to fund operations into 4Q24
1M ago
CLNN
Clene reports 2023 EPS (47c), consensus (45c)
PremiumThe Fly
Clene reports 2023 EPS (47c), consensus (45c)
1M ago
CLNN
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights
PremiumPress Releases
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights
1M ago
CLNN
Clene Announces Breakthrough CNM-Au8 Treatment Results
PremiumCompany AnnouncementsClene Announces Breakthrough CNM-Au8 Treatment Results
2M ago
8K
CLNN
Clene presents clinical results of CNM-Au8 30mg treatment
PremiumThe Fly
Clene presents clinical results of CNM-Au8 30mg treatment
2M ago
CLNN
Clene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum 2024
PremiumPress Releases
Clene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum 2024
2M ago
CLNN
Clene’s CNM-Au8 Shows Promise in ALS Survival Rates
PremiumCompany Announcements
Clene’s CNM-Au8 Shows Promise in ALS Survival Rates
2M ago
8K
CLNN
Clene reports ‘significant’ survival results from two analyses of CNM-Au8
PremiumThe Fly
Clene reports ‘significant’ survival results from two analyses of CNM-Au8
2M ago
CLNN
Clene Inc. Faces Nasdaq Delisting Over Price Woes
PremiumCompany Announcements
Clene Inc. Faces Nasdaq Delisting Over Price Woes
3M ago
8K
CLNN
Clene reports new CNM-Au8 results from VISIONARY-MS trial
PremiumThe Fly
Clene reports new CNM-Au8 results from VISIONARY-MS trial
3M ago
CLNN
Clene announces new data from HEALEY ALS Platform Trial
PremiumThe FlyClene announces new data from HEALEY ALS Platform Trial
4M ago
CLNN
Clene Provides Update on ALS Clinical Development Meeting With FDA
PremiumPress Releases
Clene Provides Update on ALS Clinical Development Meeting With FDA
4M ago
CLNN
Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension
PremiumPress Releases
Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension
4M ago
CLNN
Clene announces FDA said NfL reduction insufficient for accelerated approval
PremiumThe Fly
Clene announces FDA said NfL reduction insufficient for accelerated approval
4M ago
CLNN
Clene Announces Peer-Reviewed Publication Describing CNM-Au8 Brain Target Engagement In Neurodegenerative Diseases
PremiumPress Releases
Clene Announces Peer-Reviewed Publication Describing CNM-Au8 Brain Target Engagement In Neurodegenerative Diseases
4M ago
CLNN
Clene announces peer-reviewed publication on CNM-Au8 brain target
PremiumThe Fly
Clene announces peer-reviewed publication on CNM-Au8 brain target
4M ago
CLNN
Clene price target lowered to $7 from $10 at Roth MKM
PremiumThe Fly
Clene price target lowered to $7 from $10 at Roth MKM
5M ago
CLNN
Clene Reports Third Quarter 2023 Financial Results and Operating Highlights
PremiumPress ReleasesClene Reports Third Quarter 2023 Financial Results and Operating Highlights
5M ago
CLNN
Clene expects cash to fund operations into 3Q24
PremiumThe Fly
Clene expects cash to fund operations into 3Q24
5M ago
CLNN
Clene reports Q3 EPS (2c), consensus (9c)
PremiumThe Fly
Clene reports Q3 EPS (2c), consensus (9c)
5M ago
CLNN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >